19 May 2011: NorDiag ASA invites to a presentation of the Q1 results 2011 on May 26, 2011 at 8:30am at Thon Hotel Vika Atrium, Munkedamsveien 45, Oslo.

Please confirm your participation to investor@nordiag.com, or by calling +47 22 02 65 91. Shareholders who wish to receive the quarterly report by mail are requested to send an email regarding this to the same email address.
Representatives from the Company will be CEO Mårten Wigstøl and CFO Tone Kvåle.
 
The report and the presentation will be published on NorDiag's homepage www.nordiag.com.

Contact:     
CFO Tone Kvåle, phone: +47 915 19 576.
 
About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and reagents) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The Company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2002 and has its headquarters in Oslo, Norway. The Company has offices and laboratories in Stockholm, Sweden, in West Chester (PA), USA and in Vienna, Austria. The group has today 41.1 man-labour years. NorDiag is listed on Oslo Stock Exchange with ticker NORD.

For further information - www.nordiag.com

Read the notice in Norwegian here